AkzoNobel will nominate – subject to shareholder approval – Ben Noteboom as a member of the supervisory board at the Annual General Meeting being held in April 2023. The board intends to subsequently elect him as chair, succeeding Nils Andersen, who will retire as chair and member of the board at the same time. This concludes a thorough search and selection process that was conducted by the supervisory board, led by deputy chair, Byron Grote.

Noteboom, a Dutch citizen, is chairman of Vopak’s supervisory board, and a member of the supervisory board of Aegon. He also chairs the board of trustees of the Cancer Center Amsterdam. His former roles include CEO and chairman of the board of management at Randstad, while he held different management positions at Dow Chemical for nearly nine years.

“The supervisory board is very pleased to announce the nomination of Ben Noteboom,” said Grote. “His strong track record in executive and non-executive roles, and his broad experience in different industries – including the chemical industry – will be valuable additions to AkzoNobel.”

“I’m excited about the opportunity to join AkzoNobel’s supervisory board, and look forward to contributing to the next phase of the company’s transformation as it makes further progress to becoming a frontrunner in the industry,” said Noteboom.

For more information, visit: www.akzonobel.com.